Core Viewpoint - The article highlights the investment value of the Guotai Sci-Tech 200 ETF (code: 589223), driven by the "924" policy measures in 2024, which are expected to reverse market liquidity and enhance the performance of the technology sector [1] Group 1: Market Dynamics - The market is experiencing a rebound in technology stocks, with the Sci-Tech 200 index showing high price elasticity and rapidly recovering valuations from the bottom [1] - The semiconductor and pharmaceutical industries are witnessing a substantial recovery in performance, supported by successful mergers and acquisitions in the Sci-Tech sector [1] Group 2: Investment Opportunities - The Sci-Tech 200 index aggregates high-elasticity small-cap stocks from the Sci-Tech board, reflecting the development direction of new productive forces [1] - Investors looking to conveniently participate in small-cap hard technology companies on the Sci-Tech board are encouraged to consider the Guotai Sci-Tech 200 ETF (code: 589223) for streamlined investment [1]

Group 1 - The core viewpoint of the article highlights the rapid growth of BD transactions and the catalytic role of technology, emphasizing the investment value of the Guotai Sci-Tech 200 ETF (589223) [1] - Over the past decade, the Chinese pharmaceutical industry has undergone a transformation driven by policy support, leading to industrial upgrades [1] - The approval of the "Implementation Plan for Supporting the Development of Innovative Drugs" by the State Council in July 2024 marks a new phase in national strategic support for innovative drug development, optimizing various policies to promote breakthroughs [1] Group 2 - China has entered the first tier of global new drug research and development, with the number of self-developed First-in-Class (FIC) drugs increasing from 9 in 2015 to 120 in 2024, representing 31% of the global pipeline, second only to the United States [1] - The international recognition of the innovation and value of Chinese innovative drugs has led to a trend of globalization, with both independent international expansion and licensing-out models experiencing significant growth [1] - The Sci-Tech 200 Index, which aggregates small-cap stocks from the Sci-Tech Board, reflects the development direction of new productive forces, making the Guotai Sci-Tech 200 ETF (589223) an attractive option for investors looking to participate in hard-tech enterprises [2]

Group 1 - The core viewpoint is that the Sci-Tech 200 ETF (Guotai, code: 589223) presents investment value due to its more balanced industry distribution compared to other broad-based indices on the Sci-Tech board, with sectors including electronics (31%), pharmaceuticals (18%), machinery (13%), chemicals (8%), and others, resulting in a relatively dispersed concentration with the top ten stocks accounting for about 11% of the total weight [1] Group 2 - The Sci-Tech 200 index is expected to provide more opportunities in a structural market, reflecting the development direction of new productive forces more comprehensively [2] - The Sci-Tech 200 ETF is designed for investors looking to conveniently participate in small-cap hard technology companies on the Sci-Tech board, allowing for a one-click investment approach [2]

Core Insights - The Sci-Tech Innovation 50 (科创50) and Sci-Tech Innovation 200 (科创200) exhibit contrasting investment styles, offering investors different risk-return choices [1] - The Sci-Tech Innovation 50, as a leader in the Sci-Tech Innovation Board, has strong institutional attributes and consists mainly of benchmark enterprises heavily favored by institutions, particularly in the semiconductor sector [1] - In contrast, the Sci-Tech Innovation 200 showcases a significant small and micro-cap growth style, with constituent companies being national-level "specialized, refined, and innovative" enterprises that invest heavily in R&D [1] Investment Opportunities - The R&D expenditure as a percentage of revenue for the Sci-Tech Innovation 200 constituents is higher than that of the broader growth representative, the Sci-Tech Innovation 50 index, indicating a strong driver for future profit improvement and sustained high growth [1] - Small and medium-sized enterprises on the Sci-Tech Innovation Board are experiencing dual drivers of profit growth and valuation recovery [1] - The Sci-Tech Innovation 200 index focuses on hard technology sectors such as electronics, biomedicine, and machinery, covering emerging companies with a median market capitalization of approximately 7.8 billion [1] Product Offering - The newly launched Sci-Tech Innovation 200 ETF (国泰, 589223) provides investors with a convenient way to invest in small-cap hard technology companies on the Sci-Tech Innovation Board [1]